FROM Carolyn Y. Johnson
An old drug gets a ridiculously high price….again Are incentives for so-called "orphan drugs" being misused to jack up the price of one medication by 4000 percent? Photo by Chris Potter A rare form of muscular dystrophy has long been treated in the US by a steroid imported from overseas at a price of $1200 a year. Now the FDA has approved its manufacture and distribution in this country by the drug company Marathon. The new price is $89,000 a year — reduced to $54,000 after rebates and discounts. We get perspective from Carolyn Johnson, who covers the business of medicine for the Washington Post , and Dr. Aaron Kesselheim, a professor of medicine at Harvard, where he's also Director of the program on Regulation, Therapeutics and Law.
Do Hungry Monkeys Live Longer? For 70 years, it's been known that the lives of yeast, flies and laboratory rats can be extended by dramatically cutting the number of calories in their diets. Now, after two decades of research, scientists in Wisconsin have done the same with rhesus monkeys, animals which are much more like human beings. We hear more from Carolyn Johnson of the Boston Globe .
Is Venezuela becoming a dictatorship? Venezuela may have the world's largest oil reserves, but it's a nation in trouble… economically and politically. Is a populist promise to rescue democracy turning out to be a prelude to dictatorship?
The flight bumping heard around 'round the world Recent video of a passenger forcibly removed from a United Airlines plane is a worst-case example of what's happened since consolidation into just four US-based carriers. Management seems to be tone-deaf to a decline in service — and even abuse — of passengers.
After Syria strike a new Trump doctrine emerges The President who promised an end to entanglements in the Middle East and snuggled up to Vladimir Putin has now outraged Russia with surprise missile attacks on Syria. That's raised questions about who's running the White House? We hear a variety of answers.
Will the march for science politicize objective research? Protesters are gathering all over the country for tomorrow's Earth Day March for Science. Since President Trump has proposed massive cuts in basic scientific research, will the movement be perceived as partisan politics — whether scientists themselves like it or not?